AU2003302609B9 - Novel chi-conotoxin peptides (-I) - Google Patents

Novel chi-conotoxin peptides (-I) Download PDF

Info

Publication number
AU2003302609B9
AU2003302609B9 AU2003302609A AU2003302609A AU2003302609B9 AU 2003302609 B9 AU2003302609 B9 AU 2003302609B9 AU 2003302609 A AU2003302609 A AU 2003302609A AU 2003302609 A AU2003302609 A AU 2003302609A AU 2003302609 B9 AU2003302609 B9 AU 2003302609B9
Authority
AU
Australia
Prior art keywords
cys
xaal
seq
xaa3
lys leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003302609A
Other languages
English (en)
Other versions
AU2003302609B2 (en
AU2003302609A1 (en
Inventor
Dianne Alewood
Paul Francis Alewood
Richard James Lewis
Elka Palant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenome Ltd
Original Assignee
Xenome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenome Ltd filed Critical Xenome Ltd
Publication of AU2003302609A1 publication Critical patent/AU2003302609A1/en
Publication of AU2003302609B2 publication Critical patent/AU2003302609B2/en
Application granted granted Critical
Publication of AU2003302609B9 publication Critical patent/AU2003302609B9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003302609A 2002-12-02 2003-12-02 Novel chi-conotoxin peptides (-I) Ceased AU2003302609B9 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43030602P 2002-12-02 2002-12-02
US60/430,306 2002-12-02
PCT/AU2003/001605 WO2004050690A1 (en) 2002-12-02 2003-12-02 NOVEL χ-CONOTOXIN PEPTIDES (-I)

Publications (3)

Publication Number Publication Date
AU2003302609A1 AU2003302609A1 (en) 2004-06-23
AU2003302609B2 AU2003302609B2 (en) 2008-03-20
AU2003302609B9 true AU2003302609B9 (en) 2008-05-15

Family

ID=32469446

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302609A Ceased AU2003302609B9 (en) 2002-12-02 2003-12-02 Novel chi-conotoxin peptides (-I)

Country Status (13)

Country Link
US (1) US7851444B2 (https=)
EP (1) EP1572725B1 (https=)
JP (1) JP4565087B2 (https=)
AT (1) ATE547424T1 (https=)
AU (1) AU2003302609B9 (https=)
CA (1) CA2508129C (https=)
CY (1) CY1112839T1 (https=)
DK (1) DK1572725T3 (https=)
ES (1) ES2383358T3 (https=)
NZ (1) NZ540518A (https=)
PT (1) PT1572725E (https=)
SI (1) SI1572725T1 (https=)
WO (1) WO2004050690A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP2412719A1 (en) * 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides
US8062623B2 (en) * 2004-10-15 2011-11-22 Velocys Stable, catalyzed, high temperature combustion in microchannel, integrated combustion reactors
US20070154360A1 (en) * 2005-10-13 2007-07-05 Velocys Inc. Microchannel apparatus comprising a platinum aluminide layer and chemical processes using the apparatus
CN102752032B (zh) 2011-04-22 2015-04-22 艾利森电话股份有限公司 同频负载均衡方法及其设备
WO2016191200A1 (en) * 2015-05-22 2016-12-01 Clemson University Conotoxin peptides for use in biofouling deterrence
CN119462881A (zh) * 2024-12-20 2025-02-18 深圳肽盛生物科技有限公司 μ型芋螺毒素肽及其药物组合物和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051403A (en) 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
PH30083A (en) 1991-02-25 1996-12-27 Lilly Co Eli Treatment of lower urinary tract disorders
SG50624A1 (en) * 1991-12-30 1998-07-20 Neurex Corp Methods of producing analgesia and enhancing opiate analgesia
AU715165B2 (en) 1994-11-03 2000-01-20 Novartis Ag Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
WO1996040064A1 (en) 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
DE69627153T2 (de) 1995-06-27 2003-12-04 Elan Pharmaceuticals, Inc.(N.D.Ges.D.Staates Delaware) Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
JP3238414B2 (ja) 1996-02-22 2001-12-17 ニューロサーチ・アクティーゼルスカブ トロパン―誘導体、その製造方法及びその使用方法
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
CZ288739B6 (cs) 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
WO1998022126A1 (en) 1996-11-18 1998-05-28 University Of Utah Research Foundation USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
WO1998051668A1 (en) 1997-05-14 1998-11-19 Neurosearch A/S Piperidine derivatives as neurotransmitter re-uptake inhibitors
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
US6767896B1 (en) * 1999-01-29 2004-07-27 Cognetix, Inc. Conotoxin peptides
AU3473800A (en) 1999-01-29 2000-08-18 University Of Utah Research Foundation Conotoxin peptides
US20010036943A1 (en) 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
US20030170222A1 (en) * 2001-01-29 2003-09-11 University Of Utah Research Foundation Beta-superfamily conotoxins
WO2002064740A2 (en) 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
EP2412719A1 (en) 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides

Also Published As

Publication number Publication date
CY1112839T1 (el) 2016-02-10
EP1572725A4 (en) 2008-09-24
ATE547424T1 (de) 2012-03-15
EP1572725B1 (en) 2012-02-29
AU2003302609B2 (en) 2008-03-20
WO2004050690A1 (en) 2004-06-17
US7851444B2 (en) 2010-12-14
SI1572725T1 (sl) 2012-08-31
JP4565087B2 (ja) 2010-10-20
EP1572725A1 (en) 2005-09-14
DK1572725T3 (da) 2012-06-18
AU2003302609A1 (en) 2004-06-23
CA2508129C (en) 2012-06-26
CA2508129A1 (en) 2004-06-17
ES2383358T3 (es) 2012-06-20
US20060142201A1 (en) 2006-06-29
JP2006523181A (ja) 2006-10-12
NZ540518A (en) 2006-12-22
HK1080870A1 (en) 2006-05-04
PT1572725E (pt) 2012-05-28

Similar Documents

Publication Publication Date Title
US20090088389A1 (en) Novel x-conotoxin peptides (-ii)
TW200902068A (en) GLP-1 peptide having sugar chain attached thereto
EP2015766B1 (en) Cyclised alpha-conotoxin vc1.1 for use in the oral treatment of pain
WO2008077194A1 (en) Receptor agonists
US20050215480A1 (en) Alpha conotoxin peptides with analgesic properties
AU2003302609B9 (en) Novel chi-conotoxin peptides (-I)
CA2566832A1 (en) Cyclised alpha-conotoxin peptides
NZ540582A (en) Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis B core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
WO2004099238A1 (en) NOVEL mu-CONOTOXIN PEPTIDES
US8188048B2 (en) Combination therapy
JP2002527093A (ja) コンツラキン−ｇ、そのアナログおよびそのための使用
WO2000044769A1 (en) Conotoxin peptides
HK1080870B (en) Chi-conotoxin peptides having a n-terminal pyroglutamic acid
HK1164340A (en) Chi-conotoxin peptides (ii)
HK1166808A (en) Chi-conotoxin peptides
WO2025154082A1 (en) Ubiquitin high affinity cyclic peptides and methods of use thereof
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
AU757011B2 (en) Novel peptides

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired